ZimVie Reports First Quarter 2023 Financial Results and Provides Update to Annual Guidance
03 mai 2023 16h05 HE
|
ZimVie Inc.
Third Party Net Sales of $225.1 million Net Loss of ($30.0) million; Net Loss Margin of (13.3%); Adjusted Net Income[1] of $6.7 millionDiluted EPS of ($1.14); Adjusted Diluted EPS[1] of $0.25Adjusted...
ZimVie Opens State-of-the-Art Dental Science Educational and Training Institute in Palm Beach Gardens, Florida
27 avr. 2023 08h30 HE
|
ZimVie Inc.
WESTMINSTER, Colo., April 27, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the opening of its new,...
ZimVie Announces the Recent Launches of RegenerOss® CC Allograft Particulate and RegenerOss® Bone Graft Plug
13 avr. 2023 08h30 HE
|
ZimVie Inc.
WESTMINSTER, Colo., April 13, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the recent launches of two additions...
ZimVie to Report First Quarter 2023 Financial Results on May 3, 2023
12 avr. 2023 16h10 HE
|
ZimVie Inc.
WESTMINSTER, Colo., April 12, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the...
ZimVie Announces Expanded Reimbursement and Exemplary Clinical Rating for Mobi-C®
03 avr. 2023 09h00 HE
|
ZimVie Inc.
WESTMINSTER, Colo., April 03, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that the French Republic has...
ZimVie’s Exclusive Puros® Cancellous Particulate Allograft Dental Bone Grafting Solution Excels in Landmark Comparative Study in The International Journal of Oral & Maxillofacial Implants
23 mars 2023 08h30 HE
|
ZimVie Inc.
WESTMINSTER, Colo., March 23, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the publication of an article titled...
ZimVie Announces Additional Positive Policy Decisions for Vertebral Body Tethering
15 mars 2023 08h30 HE
|
ZimVie Inc.
WESTMINSTER, Colo., March 15, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that Highmark, one of America's...
ZimVie Reports Fourth Quarter and Full Year 2022 Financial Results
01 mars 2023 16h05 HE
|
ZimVie Inc.
FY 2022 Third Party Net Sales of $909.5 million FY 2022 Net Loss of ($63.9) million; Net Loss Margin of (7.0%); Adjusted Net Income[1] of $47.9 millionFY 2022 Diluted EPS of ($2.45); Adjusted Diluted...
ZimVie Announces Launch of the RealGUIDE™ CAD and FULL SUITE Software Modules
23 févr. 2023 08h30 HE
|
ZimVie Inc.
WESTMINSTER, Colo., Feb. 23, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the launch of the RealGUIDE™ CAD and...
ZimVie to Report Fourth Quarter and Full Year 2022 Financial Results on March 1, 2023
13 févr. 2023 16h10 HE
|
ZimVie Inc.
WESTMINSTER, Colo., Feb. 13, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the...